Perfil de pacientes que abandonan un programa de rehabilitación respiratoria

Exercise Training in Patients with Chronic Respiratory Diseases: Are Cardiovascular Comorbidities and Outcomes Taken into Account?—A Systematic Review

“…The 180 studies included were conducted between 1987 and 2019. In total, 156 studies included patients with COPD [23,31,32,33,34,35,36,37,38,39,40,41,42,43,44,45,46,47,48,49,50,51,52,53,54,55,56,57,58,59,60,61,62,63,64,65,66,67,68,69,70,71,72,73,74,75,76,77,78,79,80,81,82,83,84,85,86,87,88,89,90,91,92,93,94,95,96,97,98,99,100,101,102,103,104...…”

“…In general, 22.8% of the studies [23,48,50,55,63,67,69,73,77,78,79,80,83,84,86,88,91,95,97,110,111,115,122,126,127,132,142,149,150,155,161,165,175,185,187,189,190,193,197,205,206] did not report information about the eligibility criteria, 18.3% of the studies [33,42,54,65,66,72,82,96,98,99,101,108,116,117,118,119,128,137,141,143,145,146,180,182,194,195,200,201,202,203,207,208,…”

“…Characteristics of the included studies are shown in Table 2, Table 3 and Table 4. From the 42 included studies, 32 studies included patients with COPD [33,37,42,43,44,48,49,53,54,55,57,59,68,80,85,90,101,104,106,107,108,120,121,123,124,128,129,136,146,147,151,167], two studies included patients with asthma [186,189] and eight studies included patients with ILD [196,198,201,202,203,207,208,209]. Most studies were randomized controlled trials ( n = 24; 57.1%) [37,43,44,49,53,80,85,120,121,123,124,129,146,147,151,167,186,189,196,198,202,207,208,209].…”

“…Only 13 studies in patients with COPD [33,42,43,44,48,54,55,59,68,85,101,151,167] and six studies in patients with ILD [196,198,203,207,208,209] specified the presence of patients with cardiovascular comorbidities on the population’s baseline characteristics. No studies reporting to include patients with cardiovascular comorbidities were found in asthma.…”

“…No studies reporting to include patients with cardiovascular comorbidities were found in asthma. Studies in patients with COPD included patients suffering from arterial hypertension [33,42,43,44,48,54,68,85,151] (nine studies; 314 patients), cardiovascular diseases [43,44,48,55,59,85,101,151,167] (nine studies; 247 patients), circulatory problems [42,43,44,85] (four studies; 84 patients), coronary heart disease [42] (one study; 54 patients), congestive heart failure [33,54] (two studies; 10 patients), dyslipidaemia [33,54] (two studies; 11 patients) and ischemic cardiomyopathy [33] (one study; three patients). Studies in patients with ILD included patients suffering from arterial hypertension [196,203,207,208,209] (five studies; 49 patients), coronary heart disease [207,208,209] (three studies; 21 patients), congestive heart failure [203] (one study; two patients), pulmonary hypertension [207,208,209] (three studies; 15 patients) and history of heart disease [198] (one study; one patient).…”